| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 42.98 +21.17% on 04/07/25 |
Period Open: 47.70
| 52.27 -0.36% on 04/22/25 | +4.38 (+9.18%) since 03/21/25 |
| 3-Month | 42.98 +21.17% on 04/07/25 |
Period Open: 59.38
| 61.06 -14.71% on 01/24/25 | -7.30 (-12.29%) since 01/22/25 |
| 52-Week | 28.23 +84.48% on 08/05/24 |
Period Open: 37.93
| 61.75 -15.66% on 12/17/24 | +14.15 (+37.31%) since 04/22/24 |
Q2 Bitcoin OutlookSince it’s inception, Bitcoin is the best performing asset class worldwide. However, recent market turmoil and a risk off environment have led to a 30+% pullback from the all-time high...
Bitcoin made winning headlines after Trump’s election win, only to end the first quarter of 2025 in the red. From the start of 2025, Bitcoin registered a shakiness, weighed down by speculation that the...
Bitcoin made winning headlines after Trump’s election win, only to end the first quarter of 2025 in the red. From the start of 2025, Bitcoin registered a shakiness, weighed down by speculation that the...
While choosing individual stocks is a hobby for certain people, exchange-traded funds (ETFs) are a great choice for those who prioritize convenience and simplicity with their investments. Even better,...
Strategy, formerly known as MicroStrategy, has gone all-in on Bitcoin as it calls itself the world's first Bitcoin Treasury but is it a beacon or bagholder?
Do you experience FOMO, or the fear of missing out? I do, and I'm betting you do, too. It's a risky motivator that can have you doing things you wouldn't normally consider doing, and Wall Street is a treacherous...
As a Bitcoin (CRYPTO: BTC) investor, it can be confusing to make sense of all the information out there. And that's especially the case when it comes to the weekly influx of new macroeconomic data. It's...
Tesla Misses Q1 Delivery NumbersYear-to-date, the Zacks Rank #3 (Hold) stock Tesla (TSLA) is down 26%. Meanwhile, shares have cratered more than 40% amid political backlash, slowing EV demand, tariff concerns,...
How does Bitcoin stack up against XRP in April 2025? Find out which coin may offer better value to long-term crypto investors.
Wall Street experienced massive volatility in the first quarter of 2025, largely due to trade uncertainty under the new Trump administration. This sparked concerns about rising inflation, a slowing U.S....
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
This high-growth stock may be cheaper than you think.
What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain first-hand.
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
This high-growth stock may be cheaper than you think.
What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain first-hand.
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
This high-growth stock may be cheaper than you think.
What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain first-hand.
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.
| Name | % Holdings |
|---|---|
| Grayscale Bitcoin Mini Trust ETF | 100.00% |
| Ishares Bitcoin Trust ETF | 0.00% |
| Ultra Semiconductors 2X ETF | 0.00% |
| 3rd Resistance Point | 54.00 |
| 2nd Resistance Point | 53.13 |
| 1st Resistance Point | 52.61 |
| Last Price | 52.08 |
| 1st Support Level | 51.22 |
| 2nd Support Level | 50.35 |
| 3rd Support Level | 49.83 |
| 52-Week High | 61.75 |
| Last Price | 52.08 |
| Fibonacci 61.8% | 48.95 |
| Fibonacci 50% | 44.99 |
| Fibonacci 38.2% | 41.03 |
| 52-Week Low | 28.23 |
